XML 60 R39.htm IDEA: XBRL DOCUMENT
v3.23.4

SHARE-BASED COMPENSATION (Tables) | 12 Months Ended
--- | ---
Oct. 31, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract] |
Allocated Share-based compensation expense disclosure | The impact on our results for share-based compensation was as follows:
| Years Ended October 31,
| 2023 |  | 2022 |  | 2021
| (in millions)
Cost of products and services | $ | 34 |  |  | $ | 30 |  |  | $ | 26 |
Research and development | 13 |  |  | 14 |  |  | 12 |
Selling, general and administrative | 65 |  |  | 82 |  |  | 73 |
Total share-based compensation expense | $ | 112 |  |  | $ | 126 |  |  | $ | 111 |
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions | The following assumptions were used to estimate the fair value of awards granted.
| Years Ended October 31,
| 2023 |  | 2022 |  | 2021
Stock Option Plan: |  |  |  |  |
Weighted average risk-free interest rate | 3.9% |  | 1.5% |  | 0.5%
Dividend yield | 0.6% |  | 0.5% |  | 0.7%
Weighted average volatility | 28% |  | 26% |  | 26%
Expected life | 5.5 years |  | 5.5 years |  | 5.5 years
LTPP: |  |  |  |  |
Volatility of Agilent shares | 31% |  | 29% |  | 30%
Volatility of selected peer-company shares | 22%-84% |  | 23%-81% |  | 24%-57%
Pair-wise correlation with selected peers | 42% |  | 41% |  | 45%
Post-vest restriction discount for all executive awards | 7.1% |  | 6.5% |  | 6.8%
Summary of stock option award activity | The following table summarizes employee stock option award activity of our employees and directors for 2023.
| Options Outstanding |  | Weighted Average Exercise Price
| (in thousands) |  |
Outstanding at October 31, 2022 | 1,097 |  |  | $ | 94 |
Granted | 269 |  |  | $ | 147 |
Exercised | (249) |  |  | $ | 41 |
Cancelled | (37) |  |  | $ | 142 |
Outstanding at October 31, 2023 | 1,080 |  |  | $ | 118 |
Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range | The options outstanding and exercisable for equity share-based payment awards at October 31, 2023 were as follows:
| Options Outstanding |  | Options Exercisable
Range of Exercise Prices | Number Outstanding |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |  | Number Exercisable |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value
| (in thousands) |  | (in years) |  |  |  | (in thousands) |  | (in thousands) |  | (in years) |  |  |  | (in thousands)
$40.01 - $50.00 | 210 |  |  | 1.0 |  | $ | 41 |  |  | 13,088 |  |  | 210 |  |  | 1.0 |  | $ | 41 |  |  | 13,088 |
$100.00- $110.00 | 311 |  |  | 7.0 |  | $ | 110 |  |  | — |  |  | 177 |  |  | 7.0 |  | $ | 110 |  |  | — |
$110.01 - $150.00 | 319 |  |  | 8.8 |  | $ | 143 |  |  | — |  |  | 40 |  |  | 8.3 |  | $ | 136 |  |  | — |
$150.01 & Over | 240 |  |  | 8.0 |  | $ | 161 |  |  | — |  |  | 80 |  |  | 8.0 |  | $ | 161 |  |  | — |
| 1,080 |  |  | 6.6 |  | $ | 118 |  |  | $ | 13,088 |  |  | 507 |  |  | 4.8 |  | $ | 92 |  |  | $ | 13,088 |
Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value | The following table summarizes the aggregate intrinsic value of options exercised and the fair value of options granted in 2023, 2022 and 2021:
| Aggregate Intrinsic Value |  | Weighted Average Exercise Price |  | Per Share Value Using Black-Scholes Model
| (in thousands) |  |  |  |
Options exercised in fiscal 2021 | $ | 34,305 |  |  | $ | 33 |  |  |
Black Scholes per share value of options granted during fiscal 2021 |  |  |  |  | $ | 26 |
Options exercised in fiscal 2022 | $ | 10,765 |  |  | $ | 38 |  |  |
Black Scholes per share value of options granted during fiscal 2022 |  |  |  |  | $ | 39 |
Options exercised in fiscal 2023 | $ | 25,303 |  |  | $ | 41 |  |  |
Black Scholes per share value of options granted during fiscal 2023 |  |  |  |  | $ | 47 |
Share-Based Payment Arrangement, Activity | The following table summarizes non-vested award activity in 2023 primarily for our LTPP and restricted stock unit awards.
| Shares |  | Weighted Average Grant Price
| (in thousands) |  |
Non-vested at October 31, 2022 | 2,103 |  |  | $ | 114 |
Granted | 864 |  |  | $ | 146 |
Vested | (1,096) |  |  | $ | 90 |
Forfeited | (181) |  |  | $ | 134 |
Change in LTPP shares in the year due to exceeding performance targets | 199 |  |  | $ | 79 |
Non-vested at October 31, 2023 | 1,889 |  |  | $ | 136 |

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (d)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration